secwatch / observer
8-K filed March 27, 2025, 7:59 PM ET ticker KRRO CIK 0001703647
leadership confidence high sentiment neutral materiality 0.30

Korro Bio CFO Vineet Agarwal returns from medical leave; Oliver Dolan named principal accounting officer

Korro Bio, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Vineet Agarwal

Chief Financial Officer
KRRO · Korro Bio, Inc.
Effective
2025-03-27
Filed
March 27, 2025, 7:59 PM ET
Effective March 27, 2025, Vineet Agarwal, Chief Financial Officer of Korro Bio, Inc., or the Company, ended his temporary medical leave of absence, which had been in effect since February 11, 2025.
Appointed

Oliver Dolan

Principal Accounting Officer
KRRO · Korro Bio, Inc.
Effective
2025-03-27
Filed
March 27, 2025, 7:59 PM ET
the Company’s Board of Directors appointed Mr. Oliver Dolan, age 42, current Senior Vice President, Finance, to serve as the Company’s principal accounting officer effective March 27, 2025.
Role change

Ram Aiyar

President and Chief Executive Officer
KRRO · Korro Bio, Inc.
Effective
2025-03-27
Successor
Vineet Agarwal
Filed
March 27, 2025, 7:59 PM ET
Dr. Ram Aiyar, who had been serving as the Company’s interim principal financial officer, is no longer serving in that role as of March 27, 2025 and continues to serve as the Company’s President and Chief Executive Officer (principal executive officer).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Vineet Agarwal was appointed as Chief Financial Officer at Korro Bio, Inc..

Action
reappointed
Role
Chief Financial Officer
Exact text from the filing
Effective March 27, 2025, Vineet Agarwal, Chief Financial Officer of Korro Bio, Inc., or the Company, ended his temporary medical leave of absence, which had been in effect since February 11, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Oliver Dolan was appointed as Principal Accounting Officer at Korro Bio, Inc..

Action
appointed
Role
Principal Accounting Officer
Exact text from the filing
the Company’s Board of Directors appointed Mr. Oliver Dolan, age 42, current Senior Vice President, Finance, to serve as the Company’s principal accounting officer effective March 27, 2025.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Ram Aiyar changed role as President and Chief Executive Officer at Korro Bio, Inc..

Action
no longer serving
Role
President and Chief Executive Officer
Exact text from the filing
Dr. Ram Aiyar, who had been serving as the Company’s interim principal financial officer, is no longer serving in that role as of March 27, 2025 and continues to serve as the Company’s President and Chief Executive Officer (principal executive officer).
View on SEC.gov

Korro Bio, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-064792
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.